MedPage Today's weekly 'What We Heard' feature collects notable quotes from clinicians and researchers. This week's edition spans unrelated topics, from AI-generated papers to tick-borne disease. The most pointed warning came from Elisabeth Bik, a scientific integrity consultant, who said AI-generated research has reached the point where experts cannot reliably distinguish fake from real.
Several quotes illustrate the tension between promise and proof. Victor van Berkel of UofL Physicians told an FDA advisory committee that a multicancer early detection blood test can find cancers earlier, but asked whether that earlier detection is clinically relevant. By contrast, Helen Tager-Flusberg of Boston University said she is optimistic that an HHS-led autism diagnosis initiative could be transformative.
Other remarks touched on policy and public health. Sarah Wetter of the O'Neill Institute warned that a Louisiana-centered mifepristone ruling could impose one state's abortion policy on the rest of the country. Keith Flaherty of the AACR said turmoil at NIH and other federal agencies threatens continued progress for patients, citing a 35% drop in U.S. cancer mortality since 1991. Ross Boyce of UNC described tick-borne disease diagnosis as increasingly messy as tick populations shift.